Neuberger Berman Group
JAZZ icon

Neuberger Berman Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Neuberger Berman Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
9,284
+203
+2% +$35.5K ﹤0.01% 1225
2025
Q4 		$1.54M Buy
9,081
+1,134
+14% +$174K ﹤0.01% 1264
2025
Q3 		$1.05M Buy
7,947
+2,295
+41% +$275K ﹤0.01% 1344
2025
Q2 		$600K Sell
5,652
-3,075
-35% -$334K ﹤0.01% 1529
2025
Q1 		$1.08M Sell
8,727
-263
-3% -$34.3K ﹤0.01% 1288
2024
Q4 		$1.11M Sell
8,990
-357
-4% -$42.1K ﹤0.01% 1284
2024
Q3 		$1.04M Buy
9,347
+2,130
+30% +$233K ﹤0.01% 1291
2024
Q2 		$770K Sell
7,217
-133
-2% -$14.6K ﹤0.01% 1354
2024
Q1 		$885K Buy
7,350
+601
+9% +$73.6K ﹤0.01% 1319
2023
Q4 		$830K Sell
6,749
-276
-4% -$34.4K ﹤0.01% 1334
2023
Q3 		$909K Buy
7,025
+1,259
+22% +$168K ﹤0.01% 1284
2023
Q2 		$715K Buy
5,766
+1,476
+34% +$199K ﹤0.01% 1336
2023
Q1 		$628K Buy
4,290
+476
+12% +$70.4K ﹤0.01% 1384
2022
Q4 		$608K Sell
3,814
-88
-2% -$12.9K ﹤0.01% 1387
2022
Q3 		$520K Sell
3,902
-606
-13% -$92.1K ﹤0.01% 1458
2022
Q2 		$704K Sell
4,508
-678
-13% -$104K ﹤0.01% 1392
2022
Q1 		$807K Buy
5,186
+1,755
+51% +$255K ﹤0.01% 1400
2021
Q4 		$416K Buy
3,431
+1,415
+70% +$186K ﹤0.01% 1607
2021
Q3 		$243K Buy
2,016
+16
+0.8% +$2.42K ﹤0.01% 1658
2021
Q2 		$330K Buy
2,000
+73
+4% +$12.6K ﹤0.01% 1584
2021
Q1 		$293K Sell
1,927
-89
-4% -$14.6K ﹤0.01% 1614
2020
Q4 		$322K Buy
2,016
+72
+4% +$10.7K ﹤0.01% 1498
2020
Q3 		$278K Sell
1,944
-64,414
-97% -$7.99M ﹤0.01% 1476
2020
Q2 		$7.32M Buy
66,358
+20,004
+43% +$2.21M 0.01% 775
2020
Q1 		$4.62M Sell
46,354
-5,004
-10% -$647K 0.01% 799
2019
Q4 		$7.67M Buy
+51,358
New +$6.99M 0.01% 792
2019
Q1 		– Sell
-2,814
Closed -$349K – 1567
2018
Q4 		$349K Sell
2,814
-106,988
-97% -$15.9M ﹤0.01% 1334
2018
Q3 		$18.5M Sell
109,802
-143
-0.1% -$24.6K 0.02% 665
2018
Q2 		$18.9M Sell
109,945
-7,400
-6% -$1.21M 0.02% 649
2018
Q1 		$17.7M Hold
117,345
– – 0.02% 652
2017
Q4 		$15.8M Hold
117,345
– – 0.02% 686
2017
Q3 		$17.2M Buy
117,345
+24,626
+27% +$3.72M 0.02% 652
2017
Q2 		$14.4M Buy
92,719
+37,264
+67% +$5.7M 0.02% 676
2017
Q1 		$8.05M Sell
55,455
-53,750
-49% -$7M 0.01% 781
2016
Q4 		$11.9M Sell
109,205
-21,696
-17% -$2.42M 0.02% 719
2016
Q3 		$15.9M Hold
130,901
– – 0.02% 652
2016
Q2 		$18.5M Buy
130,901
+33,401
+34% +$4.92M 0.03% 609
2016
Q1 		$12.7M Buy
97,500
+21,000
+27% +$2.61M 0.02% 705
2015
Q4 		$10.8M Sell
76,500
-56,900
-43% -$7.88M 0.01% 754
2015
Q3 		$17.7M Sell
133,400
-10,650
-7% -$1.83M 0.02% 675
2015
Q2 		$25.4M Sell
144,050
-377
-0.3% -$67.7K 0.03% 623
2015
Q1 		$25M Buy
+144,427
New +$24.8M 0.03% 624
2014
Q2 		– Sell
-135,849
Closed -$18.8M – 1734
2014
Q1 		$18.8M Buy
135,849
+29,209
+27% +$4.4M 0.02% 673
2013
Q4 		$13.5M Sell
106,640
-64,710
-38% -$6.7M 0.01% 736
2013
Q3 		$15.8M Buy
+171,350
New +$13.8M 0.02% 683

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Neuberger Berman Group's JAZZ Position: Q1 2026 in Review

Neuberger Berman Group increased its Jazz Pharmaceuticals (JAZZ) stake by 2.2% in Q1 2026, buying an estimated $35.5K and bringing the position to 9,284 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Neuberger Berman Group first reported a position in JAZZ in Q3 2013 and has held it in 45 quarters since. The position peaked at $25.4M in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Neuberger Berman Group held 9,284 shares of Jazz Pharmaceuticals worth $1.76M as of Q1 2026.
  • Neuberger Berman Group bought 203 Jazz Pharmaceuticals shares in Q1 2026, an estimated $35.5K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1225 holding.
  • Neuberger Berman Group first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 45 quarters since.
  • Neuberger Berman Group's Jazz Pharmaceuticals position peaked at $25.4M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.